OverviewSuggest Edit

22nd Century Group is a plant biotechnology company developing tobacco harm reduction and smoking cessation products. Its technology also allows the levels of cannabinoids to be decreased or increased in the cannabis plant.

TypePublic
Founded1998
HQWilliamsville, NY, US
Websitexxiicentury.com

Latest Updates

Employees (est.) (Feb 2020)67(-18%)
Revenue (FY, 2020)$28.1 M(+9%)
Share Price (Sept 2021)$3.3(+2%)
Cybersecurity ratingAMore

Key People/Management at 22nd Century Group

James A. Mish

James A. Mish

Chief Executive Officer
Juan Sanchez Tamburrino

Juan Sanchez Tamburrino

Vice President of Research and Development
John Franzino

John Franzino

Chief Financial Officer
Michael Koganov

Michael Koganov

Director
John D. Pritchard

John D. Pritchard

Vice President of Regulatory Science
Lisa Parks

Lisa Parks

VP, Acquisitions
Show more

22nd Century Group Office Locations

22nd Century Group has an office in Williamsville
Williamsville, NY, US (HQ)
8560 Main St #4
Show all (1)

22nd Century Group Financials and Metrics

22nd Century Group Revenue

22nd Century Group's revenue was reported to be $28.11 m in FY, 2020
USD

Revenue (Q1, 2021)

6.8m

Net income (Q1, 2021)

(5.0m)

EBIT (Q1, 2021)

(5.2m)

Market capitalization (9-Sept-2021)

530.0m

Closing stock price (9-Sept-2021)

3.3

Cash (31-Mar-2021)

1.3m

EV

529.4m
22nd Century Group's current market capitalization is $530 m.
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

12.3m16.6m26.4m25.8m28.1m

Revenue growth, %

44%35%59%(2%)

Cost of goods sold

12.7m17.3m25.5m25.8m

Gross profit

(429.7k)(707.9k)899.0k14.5k
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

2.2m3.9m4.5m6.1m6.9m6.3m6.3m5.8m6.5m7.1m6.4m7.3m6.8m

Cost of goods sold

2.5m4.1m4.9m6.0m6.8m6.1m6.4m5.9m6.5m6.8m

Gross profit

(273.9k)(165.1k)(340.4k)71.6k161.7k150.9k(102.9k)(86.3k)(21.1k)287.0k

Gross profit Margin, %

(12%)(4%)(8%)1%2%2%(2%)(1%)0%4%
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

13.5m3.7m604.9k485.1k1.0m

Accounts Receivable

41.0k957.1k871.3k866.9k2.2m

Prepaid Expenses

195.6k746.8k928.4k648.1k1.8m

Inventories

3.1m3.3m3.0m2.3m2.0m
Quarterly
USDFY, 2016

Revenue/Employee

267.0k

Financial Leverage

1.1 x
Show all financial metrics

22nd Century Group Operating Metrics

FY, 2016FY, 2017FY, 2018FY, 2019

Manufacturing Facilities

1111

Research Cigarettes Produced to Date

22 m24 m28 m28 m
Show all operating metrics

22nd Century Group Acquisitions / Subsidiaries

Company NameDateDeal Size
22nd Century Limited, LLC
Botanical Genetics, LLC
Goodrich Tobacco Company, LLC
Heracles Pharmaceuticals, LLC
NASCO Products, LLC

22nd Century Group Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

22nd Century Group Online and Social Media Presence

Embed Graph

22nd Century Group News and Updates

22nd Century Group Enters Global Specialty Hops Market

Geographic Expansion into Europe via the Netherlands Geographic Expansion into Europe via the Netherlands

22nd Century Group Appoints Accomplished Life Sciences and Biotechnology Executive Anthony Johnson to Board of Directors

Visionary in the Fields of Biotechnology and Genomics to Extend Broad Expertise to Company’s Strategy, Technology Development, Commercialization, and Value Creation Efforts

22nd Century Group to Ring Nasdaq Closing Bell Today, August 16

BUFFALO, N.Y., Aug. 16, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (formerly NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, announced today that it will ring the Nasda…

22nd Century Group Secures New Contract Manufacturing Agreements, Expands Distribution Network and Manufacturing Capabilities Ahead of VLN® Launch

Company will Increase Investment in Tobacco Production and Testing Equipment and Add New Talent in Preparation for Projected Demand Company will Increase Investment in Tobacco Production and Testing Equipment and Add New Talent in Preparation for Projected Demand

22nd Century Group to Host Webcast to Provide Business Update and Discuss Second Quarter 2021 Results

BUFFALO, N.Y., July 19, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, will host a live webcast on Thursday, August 5, 2021, at 10:00 AM ET…

22nd Century Group Adds Strategic Partnerships With Sawatch Agriculture and Folium Botanical for Next-Generation Commercial Hemp/Cannabis Plant Breeding and Commercial Scale-Up

BUFFALO, N.Y., July 14, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that it has added strategic partnerships with expert…
Show more

22nd Century Group Blogs

22nd Century Group Reports Business Highlights and Financial Results for the Second Quarter 2021

Initiated International Launch Process For VLN®, First Sales Planned by First Quarter 2022 First Revenue From Hemp/Cannabis Franchise to Commence in Second Half of 2021 Third Plant-Based Franchise to be Introduced on August 30, 2021 Uplisting common shares to the Nasdaq Capital Market (“Nasdaq”) an…

22nd Century Group Reports Business Highlights and Financial Results for the First Quarter 2021

Key Business and Financial Highlights 22nd Century is advancing commercial opportunities across $1.3 trillion global addressable markets in tobacco, hemp/cannabis, and a third plant-based franchise. The significant increase in the Company’s share price since reporting fourth quarter 2020 results i…

22nd Century Fully Prepared to Deliver the Solution as Biden Administration Considers Requirement to Lower Nicotine Level for All Cigarettes Sold in U.S.

Company’s Confidence Continues to Grow on Implementation of Proposed Nicotine Cap and Menthol Ban Company is Fully Prepared to Launch its VLN® Reduced Nicotine Content Cigarettes; Willing to License Reduced Nicotine Technology to Big Tobacco to Save Millions of American Lives Science Behind Benef…

22nd Century Stands Fully Prepared to Enable New Zealand Proposal to Advance Nationwide Smoke-Free Action Plan

New Zealand Ministry of Health Proposal Calls for Reducing Nicotine Content in Cigarettes to “Minimal Levels” to Help Smokers Quit, Prevent Addiction BUFFALO, N.Y., April 15, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that…

Becerra Confirmation Boosts 22nd Century’s Position to Disrupt Tobacco Industry

Confirmation of Becerra as New HHS Secretary May Reignite FDA’s Plan to Eliminate Addictive Cigarettes WILLIAMSVILLE, N.Y., March 19, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low n…

22nd Century Group Receives Additional $3.7 Million from Cash Exercise of Outstanding Warrants

WILLIAMSVILLE, N.Y., March 12, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, today announced that it has received an additional …
Show more

22nd Century Group Frequently Asked Questions

  • When was 22nd Century Group founded?

    22nd Century Group was founded in 1998.

  • Who are 22nd Century Group key executives?

    22nd Century Group's key executives are James A. Mish, Juan Sanchez Tamburrino and John Franzino.

  • How many employees does 22nd Century Group have?

    22nd Century Group has 67 employees.

  • What is 22nd Century Group revenue?

    Latest 22nd Century Group annual revenue is $28.1 m.

  • What is 22nd Century Group revenue per employee?

    Latest 22nd Century Group revenue per employee is $419.6 k.

  • Who are 22nd Century Group competitors?

    Competitors of 22nd Century Group include Cannaray, Eybna and CLS Holdings USA.

  • Where is 22nd Century Group headquarters?

    22nd Century Group headquarters is located at 8560 Main St #4, Williamsville.

  • Where are 22nd Century Group offices?

    22nd Century Group has an office in Williamsville.

  • How many offices does 22nd Century Group have?

    22nd Century Group has 1 office.